Mesa Laboratories (MLAB) Director Shiraz Ladiwala Receives RSU Award

What Happened
Shiraz Ladiwala, a director of Mesa Laboratories, was granted 2,510 restricted stock units (RSUs) on September 9, 2026. The grant is recorded as an award/acquisition at $0.00 per RSU (derivative instrument), so there was no cash purchase or sale. The RSUs are contingent rights to receive common stock upon vesting.

Key Details

• Transaction date: September 9, 2026; Form 4 filed September 11, 2026 (filed within the typical two-business-day window).
• Grant: 2,510 RSUs at $0.00 per unit (derivative award).
• Vesting: RSUs vest on September 9, 2027 (footnote).
• Shares owned after transaction: not reported in the filing.
• Footnotes: F1 — each RSU equals a contingent right to one share; F2 — vest date 9/9/2027; F3 — not applicable.

Context
RSUs are a form of equity compensation and do not represent immediately transferable shares until they vest. This award reflects compensation or retention incentives rather than an open-market purchase or sale; it does not by itself indicate a buy/sell signal.